HUAWEI HENGYUAN
Huawei Hengyuan is a biomedical technology company dedicated to the preparation of Sertoli cells (with immune immunity) in vitro using cell reprogramming technology, mainly for: autoimmune diseases (such as rheumatoid arthritis); reproductive adjuvant therapy; human body Chronic diseases (such as Parkinson's); organ/tissue colonization (such as skin allograft).
HUAWEI HENGYUAN
Industry:
Biotechnology Health Care Medical
Founded:
2018-12-01
Address:
Beijing, Beijing, China
Country:
China
Total Employee:
11+
Status:
Active
Total Funding:
0
Similar Organizations
Qinghui Liannuo
Qinghui Liannuo is a biotechnology company engaged in the development of innovative immunological drugs.
Investors List
Tsing Ventures
Tsing Ventures investment in Seed Round - Huawei Hengyuan